The Effect of GLP-1 on the Inhibition of Glucagon Secretion.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2013
At a glance
- Drugs Glucagon-like peptide-1 7-36 amide (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jan 2012 New trial record